A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2006
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724257A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
11/22/2006	EP1722821A1 Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1368014B1 Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	CN1867568A Diazabicyclononene derivatives and their use as renin inhibitors
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867351A Remedy for kidney diseases
11/22/2006	CN1867349A Composition and method of treatment for urogenital conditions
11/22/2006	CN1865289A Preparation and uses of polysaccharide from urtica fissa
11/22/2006	CN1864705A An arctium fruit extract, its preparation method and application
11/22/2006	CN1864546A A Chinese wolfberry cake and preparation process thereof
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285376C Chinese herbal medicines for various stones and their preparation
11/22/2006	CN1285372C Preparation method of Chinese medicine oral preparation for treating gynecologic inflammation
11/22/2006	CN1285340C Medicine of polysaccharide sulfate amino acid salt, its preparation and application
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138405 Pharmaceutical combinations
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138393 Biologically active vasopressin agonist metabolites
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/21/2006	US7138140 For therapy of allergic diseases, dysuria or pruritus due to kidney dialysis
11/21/2006	US7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/16/2006	WO2006122154A2 Pyridone derivatives for modulating stress-activated protein kinase system
11/16/2006	WO2006121389A1 Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity
11/16/2006	WO2006121280A1 Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis
11/16/2006	WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006	WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006120160A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
11/16/2006	WO2006089230A3 Human monoclonal antibodies to prostate specific membrane antigen (psma)
11/16/2006	WO2006078833A3 Novel coumarin derivatives as ion channel openers
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258669 Therapeutic agents useful for treating pain
11/16/2006	US20060258637 Fused polycyclic compounds
11/16/2006	US20060258595 Apoptosis of rectum and prostate gland cancer
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257474 anti-thrombocytic agent and an HMG-CoA reductase inhibitor in an amount sufficient to treat chronic glomerular nephritis wherein the anti-thrombocytic agent is selected from dilazep, dipyridamole and or salts thereof and the HMG-CoA reductase inhibitor is pitavastatin
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257392 Remedy or preventive for low turnover bone diseases
11/16/2006	US20060257351 administering, to a subject a formulation containing2-(3,4-dihydroxyphenyl)ethanol or a glucoside; and cysteine or cystine for potentiating glutathione, for promoting the production of a gamma -glutamylcysteine synthetase, glutathione reductase; antiaging agents, nutraceuticals, sunscreen agents
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	CA2608116A1 Method of modulating stress-activated protein kinase system
11/16/2006	CA2608035A1 Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis
11/16/2006	CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/15/2006	EP1721905A1 Thiazole derivative
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721608A2 Upregulation of type III endothelial cell nitric oxide synthase by HMG-CoA reductase inhibitors
11/15/2006	EP1721606A2 Buffered compositions for dialysis
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1492519B1 Methods for treating lower urinary tract disorders using antimuscarinics and alpha-2-delta subunit calcium channel modulators
11/15/2006	EP1474127B1 Biphenyl derivatives and their use as antiandrogenic agents
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863548A Methods and compositions for treating disorders of the extracellular matrix
11/15/2006	CN1863539A Buffered compositions for dialysis
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1861193A Kidney target precursor medicine, said prepn., its preparing method and application
11/15/2006	CN1861163A Traditional Chinese medicine composition for treating kidney-yang deficiency and deficiency of vital energy and blood, its prepn. process
11/15/2006	CN1861158A Dispersing tablets of Liuwei-dihuang extract or its add-substract components, and its prepn. method
11/15/2006	CN1861148A Traditional Chinese medicine pills for treating urinaemia
11/15/2006	CN1861124A Medicine for treating chronic renal insufficiency and its prepn. method
11/15/2006	CN1861079A Compounding prepn. contg. cefteram pivoxil and pidotimod
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284594C Compound Chinese medicine preparation for treating benign prostate hyperplasia and its preparation process
11/15/2006	CN1284583C Medicine for treating prostatitis
11/15/2006	CN1284572C Preparation from natural products for nourishing the liver and preparing method
11/14/2006	US7135607 Shows symptoms of diffuse alveolar hemorrhage, glomerulonephritis, and appearance of antikidney glomerular basement membrane antibody; immunizing with type IV collagen homozygous transgenic mouse whose genome comprises a disruption of the FC gamma RIIB gene; diagnosis, drug screening
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135490 Method for the treatment of glomerulonephritis
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135471 Aryl oximes

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 562